21 results about "Withania somnifera" patented technology

The invention belongs to the field of new materials for daily use chemicals, and discloses a method for fermenting solanum nigrum, which is characterized in that solanum nigrum roots are fermented by adopting one or more strains of lactic acid bacteria, bifidobacteria, bacillus, micrococcus, saccharomycetes and filamentous fungi to obtain a solanum nigrum fermentation product. The functions of wrinkle resistance, compactness and the like of the withanolaria nipponica fermentation product obtained by fermentation through the method are obviously better than those of unfermented withanolaria nipponica fermentation products and fermentation products taking withanolaria nipponica extracts as fermentation bases. Meanwhile, the invention also provides application of the fermentation product.

The present invention discloses a preparation process and application of a compound preparation of astaxanthin, lycopene and proanthocyanidins for anti-aging and prevention of prostate diseases, belonging to the field of biomedicine. The preparation is composed of astaxanthin (1-10 parts), proanthocyanidins (5-30 parts), lycopene (2-15 parts), black cumin seed oil (0.5-3 parts), Phyllanthus emblica extract (3-8 parts) and Withania somnifera extract (1-5 parts), and is prepared by high-efficiency wet granulation technology. The components act synergistically to significantly enhance antioxidant, anti-inflammatory and anti-cancer activities, and have dual effects of anti-aging and prevention and treatment of prostate diseases. Experiments show that the hydroxyl radical scavenging rate of the compound preparation is 2.3 times higher than that of the single ingredient, the inflammatory factors in the prostatitis model are reduced by 68%, the skin antioxidant capacity is increased by 55%, and the combination with finasteride can reduce the dosage of chemical drugs by 80% and reduce the risk of sexual dysfunction. Black cumin seed oil significantly improves the bioavailability of lycopene (29.7%), and the drug concentration in the prostate tissue reaches 6.5 times that in the blood, achieving high efficiency with low dosage.

There is provided an additive composition for a culture medium, the additive composition comprising a first component comprising at least one sample extract prepared from at least one natural substance, wherein the at least one natural substance is selected from the group consisting of bird's nest (BN), ginseng, Ganoderma lucidum, Mushroom, Cordyceps sinensis (CS), South African Solanum Aquilaria (ASH), and combinations thereof. The additive composition may act as an alternative source of growth factors and hormones for cell culture media to improve consumer acceptance and / or minimize production costs.

Nutritional supplements and compositions for activating cellular signaling genes in innate inflammatory pathways are described in this application. In particular, this application describes a composition containing a solid portion comprising Bacopa monnieri extract having a least 20 percent bacosides, Silybum marianum (milk thistle) extract having 70 percent to about 80 percent silymarin, milk thistle extract, Withania somnifera (ashwagandha) extract, Camellia sinensis (green tea) extract containing at least 40 percent epigallocatechin gallate and about 98 percent polyphenols; and Curcuma longa (turmeric) extract containing at least about 95 percent curcumin. The compositions also comprise a liquid portion comprising fish collagen peptides comprising about 90 percent protein and Formosa ruby quinoa water extract containing about 10 wt % extract and about 90 wt % water. These compositions improved the skin and impacted key regulatory genes associated with several important cellular pathways. Other embodiments are also described.

The present invention relates to a composition, preferably a cosmetic composition, comprising, in a cosmetically acceptable medium: at least one hypnotic solanum nigrum extract; at least one Terminalia freynii kernel extract; and at least one lactobacillus extract. The invention also relates to uses and methods of using the composition.

This invention relates to a plant composition with whitening effects and its application. The whitening plant composition includes extracts of *Scleroderma wilfordii*, *Myrothamnus flabellifolia*, and *Solanum nigrum* root. The whitening plant composition of this invention utilizes the combination of three plant extracts, resulting in a rational formulation where each active ingredient complements the others, synergistically enhancing their effects. This effectively inhibits tyrosinase activity and reduces melanin synthesis, exhibiting significant whitening efficacy. When applied to cosmetics, this plant composition results in stable products that also provide skin repair, reduce the irritation of whitening ingredients, and are suitable for various skin types, fully meeting consumers' demand for natural, gentle, and highly effective whitening products.

Disclosed herein is an advanced synergistic nano herbal composition having significant immunomodulatory and antiviral effects in human subjects, said formulation comprising the specific combination of HAVEs of Citrus limon, Cymbopogon citratus, Origanum vulgare, Thymus serpyllum, Tinospora cordifolia, Withania somnifera, Zea mays, Meyna laxiflora, Blumea lacera, Boswellia serrata, Cinnamomum verum, Mentha pipperata, Mentha arvensis, Nigella sativa, Cocos nucifera, Fagonia arabica, Azadirachta indica, Eucalyptus globulus, Citrus sinensis, Coriandrum sativum, Saccharum officinarum, Syzygium aromaticum, Dolichos biflorus. Resulting composition is sonicated to obtain the final advanced synergistic nano herbal composition having average particle size 133.2nm.

The present invention relates to a medicinal composition derived from withania somnifera extract comprising withanolides and sominone wherein said sominone in the extract is standardized in the range of 0.1-30%. Withanolides in the said composition are in the range of 10-60%. It is further comprising withanolide glycosides and withaferin A. Medicinal composition along with pharmaceutically acceptable excipients are formulated into a dosage form. It also discloses a method of preparation of said medicinal composition. Said composition is used to improve memory and cognition when administered to subjects in the appropriate dosage. Said composition is capable of enhancing the bioavailability of its constituents.

An herbal pre-mix formulation for beverage preparation and process of preparation thereof The present invention discloses an herbal pre-mix formulation for beverage preparation, the formulation comprising a primary herb selected from Himalayan Musk Root (Nardostachys jatamansi); and secondary herbs selected from Lemongrass (Cymbopogon citratus), Ashwagandha (Withania somnifera), Cinnamon (Cinnamomum verum), Spearmint (Mentha spicata), and Peppermint (Mentha piperita). The present invention also discloses a process for preparing the pre-mix formulation for beverage preparation.

The invention relates to the technical field of sleep-aiding capsules, and particularly discloses ergothioneine sleep-aiding nutritional capsules and a process thereof. The capsule is prepared from the following components in parts by mass: 80 to 120 mg of gamma-aminobutyric acid (GABA), 130 to 170 mg of a magnesium citrate compound, 20 to 28 mg of magnesium, 25 to 35 mg of nano ergothioneine, 180 to 220 mg of a South African drunken solanum extract, 15 to 25 mg of pyrroloquinoline quinone (PQQ), 8 to 12 mg of spermidine, 45 to 55 mg of jujuboside A and 1.8 to 2.2 mg of melatonin sustained-release microspheres. The prepared capsule can be used for adjusting nerve excitability and enhancing the function of a GABA receptor; the traditional Chinese medicine composition has the effects of resisting oxidation and inflammation, improving brain microenvironment, providing energy support for sleep and adjusting sleep rhythm, is more comprehensive and remarkable in effect, high in safety and small in side effect compared with a single-component product, and has a remarkable effect compared with a chemically synthesized hypnotic. The traditional Chinese medicine composition has no drug dependence and tolerance, reduces the burden on the body, and is suitable for long-term administration.

The invention disclosed herein is a synergistic herbal composition comprising extracts of Mucuna pruriens, Cynara cardunculus, Trigonella foenum graecum, Withania somnifera and L-arginine along with pharmaceutically acceptable excipients, having libido enhancing, testosterone levels increasing and ejaculation delaying properties. The present invention also disclosed herein a process for preparation of said composition.

The present invention discloses herbal cigarette formulation to achieve the complex nicotine stimulation and addresses the symptoms of nicotine rejection with eight categories of herbal ingredients, which includes nerve stimulation herbs (54-80%, preferably 65%), tobacco taste and smell giving herbs (55-80%, preferably 70%), throat clearing herbs (11-35%, preferably 17%), throat burning sensation herbs (3-12%, preferably 4%), fragrance herbs (6-20%, preferably 8%), herbs for fast absorption (4-15%, preferably 5%), herbs for preventing and treating cold and lung diseases (93-98%, preferably 98%), and herbs for preventing and treating cancer (8-20%, preferably 9%). The best formulation is disclosed as; Leucas zeylanica (Plant)- 30%; Desmodium triflorum (Plant)-30%; Vetiveria zizanioides (Root)-2%; Erythroxylum monogynum (Root)-3%; Withania Somnifera (Root)-2%; Glycyrrhiza glabra (Root)-2%; Curcuma longa (Root)-2%; Piper longum L. (Dried immature fruit)-1%; Piper nigrum L. (Dry seeds)-1.5%; Zingiber officinale roscoe (Rhizomes)-1.5%; Bee honey-5%; Justicia Adhatoda (Leaves)-10%; Phyllanthus debilis (Plant)-7%; and Saussurea lappa (Root)-3%.

The present invention discloses a synergistic herbal composition, which comprises a first component, an extract of Terminalia chebula, the extract of Terminalia chebula containing at least one metal salt or metal complex or metal chelate of a phytochemical selected from emblicanin A, chebulinic acid, gallic acid or a mixture thereof; and a second component, the second component being selected from extracts, fractions, phytochemicals or mixtures thereof derived from Withania somnifera, Tinospora cordifolia and Andrographis paniculata; and also provides a preparation process of the synergistic herbal composition, a treatment method, and uses of such a composition for improving immunity and respiratory health.

The present invention provides a novel composition comprising Ashwagandha root (Withania somnifera), Turmeric root (Curcumalonga), Lemon Balm Leaf (Melissa officinalis), Rhodiola rosea root and Bilberry fruit (Vaccinium myrtillus). The composition may be provided for use in improving physical and mental health recovery, and also for preventing cognitive decline.

The present invention relates to a composition for preventing, improving or treating obesity, comprising a complex of an extract of Ashwagandha (Withania somnifera) and an extract of Siberian chrysanthemum (Chrysanthemum zawadskii Herbich var. latilobum (Maxim.) Kitamura) as an active ingredient. The complex provided from the present invention has very excellent effects of inhibiting differentiation of adipocytes, inhibiting lipid accumulation in adipocytes, and inhibiting pancreatic lipase, and thus it can be used in a pharmaceutical composition for preventing or treating obesity and a health functional food and food composition for preventing or improving obesity.

The present invention relates to a composition for preventing, improving or treating obesity, comprising a complex of an extract of Ashwagandha (Withania somnifera) and an extract of Siberian chrysanthemum (Chrysanthemum zawadskii Herbich var. latilobum (Maxim.) Kitamura) as an active ingredient.The complex provided from the present invention has very excellent effects of inhibiting differentiation of adipocytes, inhibiting lipid accumulation in adipocytes, and inhibiting pancreatic lipase, and thus it can be used in a pharmaceutical composition for preventing or treating obesity and a health functional food and food composition for preventing or improving obesity.

The application relates to a combined use of Withania somnifera and Melatonin. In the application, after using Withania somnifera and Melatonin in combination, they have significantly synergistic effects in improving sleep and / or improving emotion. Especially, the effects of improving sleep and / or improving emotion achieved by the way of administrating Withania somnifera in the morning in combination with administrating Melatonin in the evening are better than the effects achieved by simultaneously administrating them in the evening and by administrating each of them alone.

Composition including: a) Melatonin up to 5 mg; b) Magnesium up to 500 mg c) Withania somnifera up to 2 g; d) Gamma-aminobutyric acid up to 500 mg; e) L-tryptophan up to 1 g; f) L-Theanine up to 50 mg; g) 5-Hydroxytryptophan up to 100 mg; h) Matricaria chamomilla extract up to 500 mg; i) Valeriana officinalis extract up to 800 mg; and j) Vitamin B6 up to 5 mg.

Phytotherapeutic composition for the treatment of cardiovascular diseases, including: 10-30% by weight of a flavonoid-rich extract obtained from Ginkgo biloba and standardized to contain at least 90% pure flavonoid content; 5-20% w / w of a terpenoid-rich extract obtained from hawthorn berries (Crataegus oxyacantha) and standardized to contain at least 85% pure terpenoid content; 15-25% by weight of a complex of polyunsaturated fatty acids obtained from Perilla frutescens seeds, which has a ratio of omega-3 to omega-6 fatty acids of 3:1; 10-20 wt% of a polyphenolic extract from leaves of green tea (Camellia sinensis), standardized to a content of at least 95% pure polyphenols; 5-15 wt% of a nitric oxide-enhancing alkaloid extract from beetroot (Beta vulgaris), standardized to a content of at least 80% pure alkaloids; 4-12 wt% of an extract from Terminalia arjuna, rich in flavonoids and triterpenoids to improve cardiac function and reduce oxidative stress; 3-15% w / w of an extract from Withania somnifera containing withanolides to lower blood pressure and cholesterol levels; 2-10 wt% of an extract from Ocimum sanctum, containing eugenol and rosmarinic acid, which have anti-inflammatory and antiplatelet effects; 4-12 wt% of an extract from Punica granatum, providing polyphenols and ellagitannins to improve endothelial function; 2-10% w / w of a soluble fiber complex derived from psyllium husks (Plantago ovata) to improve bioavailability and gastrointestinal tolerability; and a pharmaceutically acceptable carrier or excipient selected from the group consisting of microcrystalline cellulose, magnesium stearate and silicon dioxide.

The utility model is applicable to the technical field of South African drunken eggplant planting, and provides a dimming sunshade for South African drunken eggplant seedling culture, which comprises a greenhouse body for culturing South African drunken eggplant seedlings, a frame plate is fixedly mounted on the inner wall of the greenhouse body, two rotating shafts are rotatably mounted on the frame plate, and rollers are fixedly sleeved on the two rotating shafts; the sunshade cloth is wound on the two rollers, and a plurality of through holes with different sizes are formed in the sunshade cloth; the rotating mechanism is mounted on the frame plate and is used for rotating the two rotating shafts; the watering mechanisms are assembled on the greenhouse body and used for irrigation. According to the dimming sunshade for the South African drunken eggplant seedling culture, the problems that when an existing greenhouse is used for culturing South African drunken eggplants, different degrees of sunshade cannot be conducted according to changes of external sunlight intensity, and South African drunken eggplant seedlings cannot be automatically irrigated are solved.

Pharmacological, sanitary, or dietary preparation for use in the treatment of low salivary secretion, which includes any Withania somnifera (ashwagandha) plant extract, obtained by means of any method and at any concentration. The use of the Withania somnifera (ashwagandha) plant is intended for the treatment of low salivary secretion by the pharmacological action of the extract from any part of the plant.